Sort
46,585 grants matching “heart failure”
Protection of Ischemic Myocardium
$2,509,828Roberto Bolli · University Of Louisville · P01 · FY2014 · HL
Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and sensor-augmented pump therapy in outpatient settings
$2,509,367Remi Rabasa-Lhoret · Clinical Research Institute Of Montreal · DP3 · FY2015 · DK
WGA Study to Identify Genetic Variants Associated with CV Events in CHS
$2,502,645Bruce M Psaty · University Of Washington · R01 · FY2007 · HL
Look AHEAD: Action for Health in Diabetes
$2,502,070Mark Andrew Espeland · Wake Forest University Health Sciences · U01 · FY2011 · DK
CaMKII and InsP3-Mediated Signaling in Cardiac Myocytes
$2,500,901Donald M Bers · University Of California At Davis · P01 · FY2011 · HL
Molecular Transducers of Physical Activity and Health: NC Consortium Clinical Site
$2,500,000William E Kraus · Duke University · U01 · FY2020 · AR
Brain Tumor SPORE Grant
$2,498,496Mitchel S. Berger · University Of California, San Francisco · P50 · FY2018 · CA
Multi-disciplinary Approaches to HDL Structure, Assembly, and Functional Heterogeneity
$2,494,366W. Sean Davidson · University Of Cincinnati · P01 · FY2024 · HL
Trial to Assess Chelation Therapy (TACT)
$2,494,247Gervasio A Lamas · University Of Miami School Of Medicine · U01 · FY2008 · HL
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
$2,494,008Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2020 · HL
Deciphering novel protein quality control pathways in the nuclear periphery
$2,493,523Christian Dirk Schlieker · Yale University · DP2 · FY2011 · OD
SPRINT
$2,490,262Suzanne Oparil · University Of Alabama At Birmingham · N01 · FY2013 · HL
Disease Status Drug Metabolism and New Drug Discovery
$2,490,069Irving William Wainer · National Institute On Aging · ZIA · FY2013 · AG
Targeting the B Cell Response to Treat Antibody-Mediated Rejection
$2,489,690Stuart Johnston Knechtle · Duke University · U01 · FY2025 · AI
Protection of Ischemic Myocardium
$2,488,563Roberto Bolli · University Of Louisville · P01 · FY2015 · HL
Comprehensive Structural and Functional Mapping of the Mammalian Cardiac Nervous System
$2,486,441Kalyanam Shivkumar · University Of California Los Angeles · OT2 · FY2020 · OD
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
$2,486,169Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2021 · HL
Individualizing Therapy for Kidney and Heart Transplant Recipients
$2,485,102Peter Scott Heeger · Icahn School Of Medicine At Mount Sinai · U01 · FY2009 · AI
Solute And Water Transport In Renal Epithelia
$2,485,092Mark Knepper · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
$2,480,996Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2023 · HL
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
$2,480,272Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2022 · HL
Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Study
$2,480,000Harold I Feldman · University Of Pennsylvania · U01 · FY2014 · DK
Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Study
$2,480,000Harold I Feldman · University Of Pennsylvania · U01 · FY2015 · DK
Ketone Monitoring Approaches for DKA Risk Mitigation in People with T1D on Adjunctive SGLT2 Inhibitors (KARMA)
$2,477,577Richard E Pratley · Adventhealth Orlando · U01 · FY2025 · DK
Autocoids in Hypertension: Pathogenesis and End Organ Damage
$2,472,318Oscar A. Carretero · Henry Ford Health System · P01 · FY2016 · HL